Article Versions Notes

Zengarini C, Guglielmo A, Mussi M, Motta G, Agostinelli C, Sabattini E, Piraccini BM, Pileri A. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments. Antibodies. 2024; 13(2):32. https://doi.org/10.3390/antib13020032

Zengarini, Corrado, Alba Guglielmo, Martina Mussi, Giovanna Motta, Claudio Agostinelli, Elena Sabattini, Bianca Maria Piraccini, and Alessandro Pileri. 2024. "A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments" Antibodies 13, no. 2: 32. https://doi.org/10.3390/antib13020032

Zengarini, C., Guglielmo, A., Mussi, M., Motta, G., Agostinelli, C., Sabattini, E., Piraccini, B. M., & Pileri, A. (2024). A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments. Antibodies, 13(2), 32. https://doi.org/10.3390/antib13020032